ATE360016T1 - Ein stereoselektives verfahren zur herstellung von nukleosidanalogen - Google Patents
Ein stereoselektives verfahren zur herstellung von nukleosidanalogenInfo
- Publication number
- ATE360016T1 ATE360016T1 AT01903534T AT01903534T ATE360016T1 AT E360016 T1 ATE360016 T1 AT E360016T1 AT 01903534 T AT01903534 T AT 01903534T AT 01903534 T AT01903534 T AT 01903534T AT E360016 T1 ATE360016 T1 AT E360016T1
- Authority
- AT
- Austria
- Prior art keywords
- stereoselectively
- group
- chiroclec
- nucleoside analogues
- replaced
- Prior art date
Links
- 229940127073 nucleoside analogue Drugs 0.000 title 1
- 230000000707 stereoselective effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- YNWUIBSEOAWSHW-HIQWKFPQSA-N 5-[(e)-2-bromoethenyl]-1-[(2s,4s)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidine-2,4-dione Chemical class O1[C@@H](CO)OC[C@H]1N1C(=O)NC(=O)C(\C=C\Br)=C1 YNWUIBSEOAWSHW-HIQWKFPQSA-N 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108010056079 Subtilisins Proteins 0.000 abstract 1
- 102000005158 Subtilisins Human genes 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 108010020132 microbial serine proteinases Proteins 0.000 abstract 1
- 108010043393 protease N Proteins 0.000 abstract 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Silicon Polymers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18197700P | 2000-02-11 | 2000-02-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE360016T1 true ATE360016T1 (de) | 2007-05-15 |
Family
ID=22666589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01903534T ATE360016T1 (de) | 2000-02-11 | 2001-02-02 | Ein stereoselektives verfahren zur herstellung von nukleosidanalogen |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6541625B2 (de) |
| EP (1) | EP1265890B1 (de) |
| JP (1) | JP2003522769A (de) |
| AT (1) | ATE360016T1 (de) |
| AU (1) | AU3144801A (de) |
| CA (1) | CA2399062C (de) |
| DE (1) | DE60127946D1 (de) |
| ES (1) | ES2284613T3 (de) |
| WO (1) | WO2001058894A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100376570C (zh) * | 2000-10-13 | 2008-03-26 | 希拉生物化学股份有限公司 | 改善胞间传输的二氧戊环类似物 |
| AU2003245663A1 (en) * | 2002-06-28 | 2004-01-19 | Altus Biologics Inc. | Process for the enzymatic resolution of 1,3-dioxolane-4-carboxylates |
| DE10335061B4 (de) * | 2003-07-31 | 2005-11-17 | Wacker-Chemie Gmbh | Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten |
| KR101157468B1 (ko) | 2004-02-03 | 2012-07-06 | 에모리 유니버시티 | 1,3-디옥솔란 뉴클레오시드 제조방법 |
| BRPI0813036A2 (pt) * | 2007-07-30 | 2017-10-24 | Rfs Pharma Llc | processo estereosseletivo para preparar derivados do nucleosídeo dioxolana de purina. |
| US8003361B2 (en) * | 2007-10-01 | 2011-08-23 | Cargill Incorporated | Production of monatin enantiomers |
| US8367847B2 (en) * | 2007-10-01 | 2013-02-05 | Cargill, Incorporated | Production of monatin enantiomers |
| US8076107B2 (en) * | 2007-10-01 | 2011-12-13 | Cargill, Incorporated | Production of monatin stereoisomers |
| WO2011030353A2 (en) * | 2009-09-08 | 2011-03-17 | University Of Delhi | Regioselective acylation of nucleosides |
| CN105503838B (zh) * | 2015-08-26 | 2017-05-31 | 广西慧宝源医药科技有限公司 | 曲沙他滨的合成及其晶型 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5283346A (en) * | 1989-03-23 | 1994-02-01 | Hoffmann-La Roche Inc. | Dioxolanes |
| US6069252A (en) * | 1990-02-01 | 2000-05-30 | Emory University | Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers |
| DE59208719D1 (de) * | 1991-08-30 | 1997-08-28 | Hoechst Ag | Verfahren zur Herstellung von optisch aktivem Vinylglycin in freier oder geschützter Form über eine enzymatische, enantioselektive Hydrolyse |
| ES2230790T3 (es) * | 1992-01-15 | 2005-05-01 | E.R. SQUIBB & SONS, INC. | Procedimientos enzimaticos para la resolucion de mezclas enantiomericas de compuestos utiles como intermedios en la preparacion de taxanos. |
| GB9525606D0 (en) * | 1995-12-14 | 1996-02-14 | Iaf Biochem Int | Method and compositions for the synthesis of dioxolane nucleosides with - configuration |
| IL143867A0 (en) * | 1998-12-23 | 2002-04-21 | Shire Biochem Inc | Antiviral nucleoside analogues |
| AU2653200A (en) * | 1999-02-11 | 2000-08-29 | Biochem Pharma Inc. | Stereoselective synthesis of nucleoside analogues |
-
2001
- 2001-02-02 WO PCT/CA2001/000117 patent/WO2001058894A1/en not_active Ceased
- 2001-02-02 EP EP01903534A patent/EP1265890B1/de not_active Expired - Lifetime
- 2001-02-02 AU AU31448/01A patent/AU3144801A/en not_active Abandoned
- 2001-02-02 DE DE60127946T patent/DE60127946D1/de not_active Expired - Lifetime
- 2001-02-02 ES ES01903534T patent/ES2284613T3/es not_active Expired - Lifetime
- 2001-02-02 CA CA002399062A patent/CA2399062C/en not_active Expired - Lifetime
- 2001-02-02 AT AT01903534T patent/ATE360016T1/de not_active IP Right Cessation
- 2001-02-02 JP JP2001558444A patent/JP2003522769A/ja active Pending
- 2001-02-09 US US09/779,853 patent/US6541625B2/en not_active Expired - Lifetime
-
2003
- 2003-02-24 US US10/370,470 patent/US6743910B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001058894A1 (en) | 2001-08-16 |
| DE60127946D1 (de) | 2007-05-31 |
| JP2003522769A (ja) | 2003-07-29 |
| US6743910B2 (en) | 2004-06-01 |
| ES2284613T3 (es) | 2007-11-16 |
| US20030187262A1 (en) | 2003-10-02 |
| US20020006635A1 (en) | 2002-01-17 |
| AU3144801A (en) | 2001-08-20 |
| CA2399062C (en) | 2010-01-12 |
| EP1265890B1 (de) | 2007-04-18 |
| EP1265890A1 (de) | 2002-12-18 |
| US6541625B2 (en) | 2003-04-01 |
| CA2399062A1 (en) | 2001-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59008105D1 (de) | Modifiziertes Phosphoramidit-Verfahren zur Herstellung von modifizierten Nukleinsäuren. | |
| DE69840678D1 (de) | Verfahren zur produktion von purinnukleosiden durch fermentation | |
| DE59608521D1 (de) | Verfahren zur herstellung von o-acetylserin, l-cystein und l-cystein-verwandten produkten | |
| DE69937223D1 (de) | Verfahren zur synthese von nukleinsäuren | |
| DE69208144D1 (de) | Verfahren zur diastereoselektiven Synthese von Nukleosiden | |
| DE60127946D1 (de) | Ein stereoselektives verfahren zur herstellung von nukleosidanalogen | |
| DE69322708D1 (de) | Neues Verfahren zur Herstellung von 7-(substituierten)-9-[(substistuierter Glycyl)amido]-6-demethyl-6-deoxytetracyclinen | |
| ATE150487T1 (de) | Verfahren zur herstellung von cytidin-diphosphat- cholin | |
| DE69132276D1 (de) | Verfahren zur herstellung von nukleotiden | |
| DE69011880D1 (de) | Verfahren zur Herstellung von L-Aminosäuren durch Fermentation. | |
| DE69125614D1 (de) | Verfahren zur herstellung c-terminal amidierter peptide | |
| DE3851022D1 (de) | Verfahren zur Herstellung von verzweigten Fructo-Oligosacchariden. | |
| DE60120352D1 (de) | Verfahren zur industriellen herstellung von betulinsäuren | |
| DE69401698D1 (de) | Verfahren zur Herstellung von 2',3'-didehydro-2'3'-didesoxynukleosiden im Grossmassstab | |
| DE60227595D1 (de) | Verfahren zur Herstellung von Cytosin-Nukleosidverbindungen | |
| ATE56472T1 (de) | Verfahren zur herstellung aromatisch substituierter l-aminosaeuren. | |
| ATE42203T1 (de) | Semi-synthetisches verfahren zur herstellung von insulin. | |
| ATE239695T1 (de) | Stereoselektive verfahren zur herstellung von gabapentinanalogen | |
| DE59010027D1 (de) | Verfahren zur diskontinuierlichen Herstellung von L-Carnitin auf mikrobiologischem Weg | |
| DE68912236D1 (de) | Verfahren zur Herstellung von hochgradig ungesättigten Fettsäuren. | |
| DE602004022639D1 (de) | Verfahren zur herstellung von lactonase und nutzung davon | |
| ATE124947T1 (de) | Verfahren zur herstellung substituierter cyclobutane. | |
| DE69515770D1 (de) | Verfahren zur Produktion von Thiophospholipiden des Aether-Typs | |
| DE69914493D1 (de) | Verfahren zur herstellung von 2-hydroxy-6-trifluormethylpyridin | |
| DE60032453D1 (de) | Ein verfahren zur synthese von ritonavir |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |